These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22025384)

  • 41. Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness.
    Moen LV; Ramberg H; Zhao S; Grytli HH; Sveen A; Berge V; Skotheim RI; Taskén KA; Skålhegg BS
    Urol Oncol; 2017 Mar; 35(3):111.e1-111.e8. PubMed ID: 27838142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer.
    Shen H; Zhang L; Zhou J; Chen Z; Yang G; Liao Y; Zhu M
    Med Sci Monit; 2017 Jan; 23():216-222. PubMed ID: 28085790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer.
    Yan J; Yang B; Lin S; Xing R; Lu Y
    Gastric Cancer; 2019 Mar; 22(2):302-313. PubMed ID: 30178386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
    Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
    Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
    Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 47. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
    Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV
    Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stretch-induced Expression of CYR61 Increases the Secretion of IL-8 in A549 Cells via the NF-κβ/lκβ Pathway.
    Zhang Y; Guf P; Yao SL; Yang D; Lv Y; Ding DF
    Curr Med Sci; 2018 Aug; 38(4):672-678. PubMed ID: 30128877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.
    Xie JJ; Xu LY; Wu JY; Shen ZY; Zhao Q; Du ZP; Lv Z; Gu W; Pan F; Xu XE; Xie D; Li EM
    Am J Pathol; 2010 Feb; 176(2):939-51. PubMed ID: 20056838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?
    Menschikowski M; Hagelgans A; Fuessel S; Mareninova OA; Neumeister V; Wirth MP; Siegert G
    Inflammation; 2012 Jun; 35(3):1113-8. PubMed ID: 22189868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.
    Chen CC; Mo FE; Lau LF
    J Biol Chem; 2001 Dec; 276(50):47329-37. PubMed ID: 11584015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
    Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
    Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
    Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
    Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
    Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
    Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.
    Qian X; Li C; Pang B; Xue M; Wang J; Zhou J
    PLoS One; 2012; 7(5):e37225. PubMed ID: 22615945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.
    Elliott B; Zackery DL; Eaton VA; Jones RT; Abebe F; Ragin CC; Khan SA
    Carcinogenesis; 2018 Apr; 39(4):546-555. PubMed ID: 29474521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
    Hormaechea-Agulla D; Gahete MD; Jiménez-Vacas JM; Gómez-Gómez E; Ibáñez-Costa A; L-López F; Rivero-Cortés E; Sarmento-Cabral A; Valero-Rosa J; Carrasco-Valiente J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Tsomaia N; Swanson SM; Culler MD; Requena MJ; Castaño JP; Luque RM
    Mol Cancer; 2017 Aug; 16(1):146. PubMed ID: 28851363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.